APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting Melatonin Receptor Agonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Long-acting Melatonin Receptor Agonists Industry Growth and Trends Forecast to 2032

20 December 2025102 pages

Choose your research edition.

Industry ResearchLong-acting Melatonin Receptor Agonists Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting Melatonin Receptor Agonists Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Long-acting Melatonin Receptor Agonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting Melatonin Receptor Agonists Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting Melatonin Receptor Agonists Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Long-acting Melatonin Receptor Agonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Long-acting Melatonin Receptor Agonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Long-acting Melatonin Receptor Agonists market include Takeda, Sichuan Kelun Pharmaceuticals, Sichuan Guowei Pharmaceuticals, Novartis, Jiangsu Hausen Pharmaceuticals, Hangzhou Lingye Pharmaceutical Technology, Guangdong Annuo Pharmaceuticals, Vanda Pharmaceuticals and Servier Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Long-acting Melatonin Receptor Agonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Long-acting Melatonin Receptor Agonists market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Long-acting Melatonin Receptor Agonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Long-acting Melatonin Receptor Agonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Long-acting Melatonin Receptor Agonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Long-acting Melatonin Receptor Agonists Market by Company

Takeda

Sichuan Kelun Pharmaceuticals

Sichuan Guowei Pharmaceuticals

Novartis

Jiangsu Hausen Pharmaceuticals

Hangzhou Lingye Pharmaceutical Technology

Guangdong Annuo Pharmaceuticals

Vanda Pharmaceuticals

Servier Laboratories

Rovi Pharma

Nectid Inc

Dr Reddy's Laboratories

Long-acting Melatonin Receptor Agonists Segment by Type

Ramelteon

Agomelatine

Other

Long-acting Melatonin Receptor Agonists Segment by Application

Hospital

Clinic

Other

Long-acting Melatonin Receptor Agonists Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting Melatonin Receptor Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting Melatonin Receptor Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting Melatonin Receptor Agonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Long-acting Melatonin Receptor Agonists companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Long-acting Melatonin Receptor Agonists Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2021-2026) Table 4. Global Long-acting Melatonin Receptor Agonists Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2027-2032) Table 6. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Long-acting Melatonin Receptor Agonists Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2026) Table 9. Global Long-acting Melatonin Receptor Agonists Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Long-acting Melatonin Receptor Agonists Market Size Share Forecasted by Type (2027-2032) Table 11. North America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Long-acting Melatonin Receptor Agonists Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2026) Table 24. Global Long-acting Melatonin Receptor Agonists Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Long-acting Melatonin Receptor Agonists Market Size Share Forecasted by Application (2027-2032) Table 26. North America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Long-acting Melatonin Receptor Agonists Industry Trends Table 37. Long-acting Melatonin Receptor Agonists Industry Drivers Table 38. Long-acting Melatonin Receptor Agonists Industry Opportunities and Challenges Table 39. Long-acting Melatonin Receptor Agonists Industry Restraints Table 40. Global Long-acting Melatonin Receptor Agonists Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Long-acting Melatonin Receptor Agonists Revenue Market Share by Company (2021-2026) Table 42. Global Long-acting Melatonin Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Long-acting Melatonin Receptor Agonists Key Company Headquarters & Area Served Table 44. Global Long-acting Melatonin Receptor Agonists Company, Product Type & Application Table 45. Global Long-acting Melatonin Receptor Agonists Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Long-acting Melatonin Receptor Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Long-acting Melatonin Receptor Agonists Product Portfolio Table 52. Takeda Recent Development Table 53. Sichuan Kelun Pharmaceuticals Company Information Table 54. Sichuan Kelun Pharmaceuticals Business Overview Table 55. Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 57. Sichuan Kelun Pharmaceuticals Recent Development Table 58. Sichuan Guowei Pharmaceuticals Company Information Table 59. Sichuan Guowei Pharmaceuticals Business Overview Table 60. Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 62. Sichuan Guowei Pharmaceuticals Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Novartis Long-acting Melatonin Receptor Agonists Product Portfolio Table 67. Novartis Recent Development Table 68. Jiangsu Hausen Pharmaceuticals Company Information Table 69. Jiangsu Hausen Pharmaceuticals Business Overview Table 70. Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 72. Jiangsu Hausen Pharmaceuticals Recent Development Table 73. Hangzhou Lingye Pharmaceutical Technology Company Information Table 74. Hangzhou Lingye Pharmaceutical Technology Business Overview Table 75. Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Product Portfolio Table 77. Hangzhou Lingye Pharmaceutical Technology Recent Development Table 78. Guangdong Annuo Pharmaceuticals Company Information Table 79. Guangdong Annuo Pharmaceuticals Business Overview Table 80. Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 82. Guangdong Annuo Pharmaceuticals Recent Development Table 83. Vanda Pharmaceuticals Company Information Table 84. Vanda Pharmaceuticals Business Overview Table 85. Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio Table 87. Vanda Pharmaceuticals Recent Development Table 88. Servier Laboratories Company Information Table 89. Servier Laboratories Business Overview Table 90. Servier Laboratories Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Servier Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio Table 92. Servier Laboratories Recent Development Table 93. Rovi Pharma Company Information Table 94. Rovi Pharma Business Overview Table 95. Rovi Pharma Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Rovi Pharma Long-acting Melatonin Receptor Agonists Product Portfolio Table 97. Rovi Pharma Recent Development Table 98. Nectid Inc Company Information Table 99. Nectid Inc Business Overview Table 100. Nectid Inc Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Nectid Inc Long-acting Melatonin Receptor Agonists Product Portfolio Table 102. Nectid Inc Recent Development Table 103. Dr Reddy's Laboratories Company Information Table 104. Dr Reddy's Laboratories Business Overview Table 105. Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio Table 107. Dr Reddy's Laboratories Recent Development Table 108. North America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2026) Table 111. North America Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Long-acting Melatonin Receptor Agonists Market Share Forecast by Country (2027-2032) Table 113. Europe Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2026) Table 116. Europe Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Long-acting Melatonin Receptor Agonists Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2026) Table 121. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Share Forecast by Country (2027-2032) Table 123. Latin America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2026) Table 126. Latin America Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Long-acting Melatonin Receptor Agonists Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2026) Table 131. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Long-acting Melatonin Receptor Agonists Product Image Figure 3. Global Long-acting Melatonin Receptor Agonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Long-acting Melatonin Receptor Agonists Market Size (2021-2032) & (US$ Million) Figure 5. Global Long-acting Melatonin Receptor Agonists Market Share by Region: 2025 VS 2032 Figure 6. Global Long-acting Melatonin Receptor Agonists Market Share by Region (2021-2032) Figure 7. North America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ramelteon Image Figure 13. Global Ramelteon Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Agomelatine Image Figure 15. Global Agomelatine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Long-acting Melatonin Receptor Agonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Long-acting Melatonin Receptor Agonists Market Share by Type 2025 VS 2032 Figure 20. North America Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2032) Figure 21. Europe Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2032) Figure 23. Latin America Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Share by Type (2021-2032) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Clinic Image Figure 28. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Long-acting Melatonin Receptor Agonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Long-acting Melatonin Receptor Agonists Market Share by Application 2025 VS 2032 Figure 33. North America Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2032) Figure 34. Europe Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2032) Figure 36. Latin America Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Long-acting Melatonin Receptor Agonists Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Long-acting Melatonin Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Long-acting Melatonin Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 43. Europe Long-acting Melatonin Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Long-acting Melatonin Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 46. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 49. Latin America Long-acting Melatonin Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Long-acting Melatonin Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 52. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Long-acting Melatonin Receptor Agonists Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Ramelteon
  • Agomelatine
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Takeda
  • Sichuan Kelun Pharmaceuticals
  • Sichuan Guowei Pharmaceuticals
  • Novartis
  • Jiangsu Hausen Pharmaceuticals
  • Hangzhou Lingye Pharmaceutical Technology
  • Guangdong Annuo Pharmaceuticals
  • Vanda Pharmaceuticals
  • Servier Laboratories
  • Rovi Pharma
  • Nectid Inc
  • Dr Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Long-acting Melatonin Receptor Agonists Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2032)
  5. 1.4.1 Global Long-acting Melatonin Receptor Agonists Market Size by Region (2021-2026)
  6. 1.4.2 Global Long-acting Melatonin Receptor Agonists Market Size by Region (2027-2032)
  7. 1.5 Key Regions Long-acting Melatonin Receptor Agonists Market Size (2021-2032)
  8. 1.5.1 North America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth Rate (2021-2032)
2 Long-acting Melatonin Receptor Agonists Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ramelteon
  3. 2.1.2 Agomelatine
  4. 2.1.3 Other
  5. 2.2 Global Long-acting Melatonin Receptor Agonists Market Size by Type
  6. 2.2.1 Global Long-acting Melatonin Receptor Agonists Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Long-acting Melatonin Receptor Agonists Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Long-acting Melatonin Receptor Agonists Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Long-acting Melatonin Receptor Agonists Market Size by Regions
  10. 2.3.1 North America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Breakdown by Type (2021-2026)
3 Long-acting Melatonin Receptor Agonists Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Long-acting Melatonin Receptor Agonists Market Size by Application
  6. 3.2.1 Global Long-acting Melatonin Receptor Agonists Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Long-acting Melatonin Receptor Agonists Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Long-acting Melatonin Receptor Agonists Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Long-acting Melatonin Receptor Agonists Market Size by Regions
  10. 3.3.1 North America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Long-acting Melatonin Receptor Agonists Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Long-acting Melatonin Receptor Agonists Industry Trends
  2. 4.2 Long-acting Melatonin Receptor Agonists Industry Drivers
  3. 4.3 Long-acting Melatonin Receptor Agonists Industry Opportunities and Challenges
  4. 4.4 Long-acting Melatonin Receptor Agonists Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Long-acting Melatonin Receptor Agonists Revenue (2021-2026)
  2. 5.2 Global Long-acting Melatonin Receptor Agonists Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Long-acting Melatonin Receptor Agonists Key Company Headquarters & Area Served
  4. 5.4 Global Long-acting Melatonin Receptor Agonists Company, Product Type & Application
  5. 5.5 Global Long-acting Melatonin Receptor Agonists Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Long-acting Melatonin Receptor Agonists Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Long-acting Melatonin Receptor Agonists Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Long-acting Melatonin Receptor Agonists Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Long-acting Melatonin Receptor Agonists Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sichuan Kelun Pharmaceuticals
  8. 6.2.1 Sichuan Kelun Pharmaceuticals Company Information
  9. 6.2.2 Sichuan Kelun Pharmaceuticals Business Overview
  10. 6.2.3 Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Kelun Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  12. 6.2.5 Sichuan Kelun Pharmaceuticals Recent Developments
  13. 6.3 Sichuan Guowei Pharmaceuticals
  14. 6.3.1 Sichuan Guowei Pharmaceuticals Company Information
  15. 6.3.2 Sichuan Guowei Pharmaceuticals Business Overview
  16. 6.3.3 Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Guowei Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  18. 6.3.5 Sichuan Guowei Pharmaceuticals Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Long-acting Melatonin Receptor Agonists Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Jiangsu Hausen Pharmaceuticals
  26. 6.5.1 Jiangsu Hausen Pharmaceuticals Company Information
  27. 6.5.2 Jiangsu Hausen Pharmaceuticals Business Overview
  28. 6.5.3 Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Jiangsu Hausen Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  30. 6.5.5 Jiangsu Hausen Pharmaceuticals Recent Developments
  31. 6.6 Hangzhou Lingye Pharmaceutical Technology
  32. 6.6.1 Hangzhou Lingye Pharmaceutical Technology Company Information
  33. 6.6.2 Hangzhou Lingye Pharmaceutical Technology Business Overview
  34. 6.6.3 Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Hangzhou Lingye Pharmaceutical Technology Long-acting Melatonin Receptor Agonists Product Portfolio
  36. 6.6.5 Hangzhou Lingye Pharmaceutical Technology Recent Developments
  37. 6.7 Guangdong Annuo Pharmaceuticals
  38. 6.7.1 Guangdong Annuo Pharmaceuticals Company Information
  39. 6.7.2 Guangdong Annuo Pharmaceuticals Business Overview
  40. 6.7.3 Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Guangdong Annuo Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  42. 6.7.5 Guangdong Annuo Pharmaceuticals Recent Developments
  43. 6.8 Vanda Pharmaceuticals
  44. 6.8.1 Vanda Pharmaceuticals Company Information
  45. 6.8.2 Vanda Pharmaceuticals Business Overview
  46. 6.8.3 Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Vanda Pharmaceuticals Long-acting Melatonin Receptor Agonists Product Portfolio
  48. 6.8.5 Vanda Pharmaceuticals Recent Developments
  49. 6.9 Servier Laboratories
  50. 6.9.1 Servier Laboratories Company Information
  51. 6.9.2 Servier Laboratories Business Overview
  52. 6.9.3 Servier Laboratories Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Servier Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio
  54. 6.9.5 Servier Laboratories Recent Developments
  55. 6.10 Rovi Pharma
  56. 6.10.1 Rovi Pharma Company Information
  57. 6.10.2 Rovi Pharma Business Overview
  58. 6.10.3 Rovi Pharma Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Rovi Pharma Long-acting Melatonin Receptor Agonists Product Portfolio
  60. 6.10.5 Rovi Pharma Recent Developments
  61. 6.11 Nectid Inc
  62. 6.11.1 Nectid Inc Company Information
  63. 6.11.2 Nectid Inc Business Overview
  64. 6.11.3 Nectid Inc Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Nectid Inc Long-acting Melatonin Receptor Agonists Product Portfolio
  66. 6.11.5 Nectid Inc Recent Developments
  67. 6.12 Dr Reddy's Laboratories
  68. 6.12.1 Dr Reddy's Laboratories Company Information
  69. 6.12.2 Dr Reddy's Laboratories Business Overview
  70. 6.12.3 Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Dr Reddy's Laboratories Long-acting Melatonin Receptor Agonists Product Portfolio
  72. 6.12.5 Dr Reddy's Laboratories Recent Developments
7 North America
  1. 7.1 North America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  3. 7.3 North America Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  3. 8.3 Europe Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  3. 10.3 South America Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Long-acting Melatonin Receptor Agonists Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst